Hackensack Using New Endovascular Stent for Treatment of an Emergent Complicated Type B Aortic Dissection

What you need to know

Hackensack is one of the first hospitals the U.S. to use Cook Medical’s Zenith Dissection Endovascular System to treat an emergent complicated Type B aortic dissection.

The new endovascular stent received FDA approval at the end of 2018, providing a less invasive alternative to open surgery.

Michael Wilderman, M.D., FACS, chief of Endovascular Surgery at Hackensack was Hackensack's principal investigator for the system's STABLE II pivotal clinical trial, and Hackensack was one of the study's lead enrollers.

How it works

The Zenith system is inserted via a catheter through the femoral artery in the groin and is carefully guided to the location in the aorta where the tear begins. Once in place, the device helps to prevent the aorta from rupturing and can reestablish vital blood supply to other areas of the body. It is less invasive than other treatment options for aortic dissection repair, and offers quicker recovery times for patients. Before it was approved by the FDA, the device underwent two multi-year clinical trials with multiple centers participating around the world, including Hackensack.

For more information

Call the Heart & Vascular Hospital at Hackensack at 201-996-2428 for more information about the Zenith system.

To schedule a patient appointment, call central scheduling at 866-411-4862.